The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Home-based medication review in a high risk elderly population in primary care—the POLYMED randomised controlled trial
Abstract
OBJECTIVE: To assess whether home-based medication review by a pharmacist for at-risk older patients in a primary care setting can reduce hospital admissions. DESIGN: Randomised controlled trial comparing home-based medication review with standard care. SETTING: Home-based medication review of 136 patients registered with one general practice. METHOD: Study participants were over 80 years of age, living at home, taking four or more medicines, and had at least one additional medicines-related risk factor. The intervention comprised two home visits by a community pharmacist who educated the patient/carer about their medicines, noted any pharmaceutical care issues, assessed need for an adherence aid, and subsequently met with the lead GP to agree on actions. MAIN OUTCOME MEASURE: Total non-elective hospital admissions within 6 months. Secondary outcomes included number of deaths, care home admissions and quality of life (EQ-5d). Impact on number of medicines prescribed was also assessed. RESULTS: At 6 months, no difference in hospital admissions (21 intervention versus 20 control P = 0.80), and no difference in care home admissions or deaths were detected between groups. There was a small (non-significant) decrease in quality of life in the intervention group. There was a statistically significant reduction in the mean number of medicines prescribed ( -0.87 items in favour of the intervention group, 95% confidence interval -1.66 to -0.08, P = 0.03). CONCLUSIONS: No positive impact on clinical outcomes or quality of life was demonstrated, however, this intervention did appear to reduce prescribing. This is in line with other evidence and suggests that this form of intervention may not have a clear health gain, but may lead to modest savings in terms of reduced prescribing. Future research should focus on whether such a prescribing effect would make this type of intervention cost effective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research evaluating the impact of collaborative medication reviews indicates that such services improve prescribing, and have the potential to reduce health service use and medication costs for patients with multiple chronic conditions [18,19].”
From From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management (2015) · cites this paper as [18]
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
National Service Framework for Older People
Baldwin, R. C. (2003) · Psychiatric Bulletin · doi:10.1192/pb.27.4.121 · Cited by 1,038
Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care
Krska, J. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.205 · Cited by 359 · cited 1×
“Trials of medication review [9, 10], where the pharmacist had direct access to medication records and closer liaison with GPs, have reported better resolution of pharmaceutical care issues and potential cost savings.”
BackgroundTHE BRITISH JOURNAL OF CLINICAL PRACTICE
(1960) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1960.tb03817.x · Cited by 342
Holland, R., Lenaghan, E., Harvey, I., Smith, R., Shepstone, L., Lipp, A., Christou, M., Evans, D., & Hand, C. (2005) · BMJ · doi:10.1136/bmj.38338.674583.ae · Cited by 331 · cited 1×
“One of the largest of these [8] showed a”
BackgroundSelf-citationZermansky, A. G., Petty, D. R., Raynor, D. K., Freemantle, N., Vail, A., & Lowe, C. J. (2001) · BMJ · doi:10.1136/bmj.323.7325.1340 · Cited by 319 · cited 2×
“Two other large studies of this type undertaken in a primary care setting [16, 17] did not show any decrease in the number of prescribed medicines.”
BackgroundA pharmacy discharge plan for hospitalized elderly patients—a randomized controlled trial
Nazareth, I., Burton, A., Shulman, S., Smith, P., Haines, A., & Timberall, H. (2001) · Age and Ageing · doi:10.1093/ageing/30.1.33 · Cited by 189
Effects of Home‐Based Intervention on Unplanned Readmissions and Out‐of‐Hospital Deaths
Stewart, S., Pearson, S., Luke, C. G., & Horowitz, J. D. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02535.x · Cited by 188 · cited 1×
“Data from a previous study [13] suggested that the level of hospital admissions could be reduced by as much as 25% over 6 months.”
BackgroundDOES ENCOURAGING GOOD COMPLIANCE IMPROVE PATIENTS' CLINICAL CONDITION IN HEART FAILURE?
Goodyer, L., Miskelly, F. G., & Milligan, P. J. (1995) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1995.tb09942.x · Cited by 122 · cited 1×
“In contrast, a number of trials have been published since ‘Polymed’ was initiated, which provide evidence in support of interventions that are focused in specific disease areas such as heart failure [14] or gastritis [15].”
BackgroundManagement ofHelicobacter pylorieradication – the influence of structured counselling and follow‐up
Aleidan, F. A. S., McElnay, J. C., Scott, M., & McConnell, J. B. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01531.x · Cited by 99 · cited 1×
“In contrast, a number of trials have been published since ‘Polymed’ was initiated, which provide evidence in support of interventions that are focused in specific disease areas such as heart failure [14] or gastritis [15].”
BackgroundZermansky, A. G., Petty, D., Raynor, D. T., Lowe, C. M., Freemantle, N., & Vail, A. (2002) · Health Technology Assessment · doi:10.3310/hta6200 · Cited by 81 · cited 2×
“At £112, the cost of the ‘Polymed’ intervention was greater than the pharmacist costs calculated in the Zermansky study [9] (£21 per hour, or £7 per patient reviewed).”
BackgroundBolton, G. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60969-5 · Cited by 72
Impact of domiciliary pharmacy visits on medication management in an elderly population
Begley, S. S., Livingstone, C. R., Hodges, N., & Williamson, V. (1997) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.1997.tb00895.x · Cited by 57 · cited 1×
“Two other large studies of this type undertaken in a primary care setting [16, 17] did not show any decrease in the number of prescribed medicines.”
"No thank you": why elderly patients declined to participate in a research study.
Petty, D. R., Zermansky, A. G., Raynor, D. K., Lowe, C. J., Buttress, A., Vail, A., & Freemantle, N. (2001) · Pharmacy World & Science · doi:10.1023/a:1011276924820 · Cited by 48 · cited 1×
“However, one study identified that many participants declined to participate as they considered themselves too unwell to attend the surgery [11].”
Background
Cited by
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Interventions to improve the appropriate use of polypharmacy for older people
Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub4 · Cited by 511
Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., & Sketris, I. (2015) · Health Policy · doi:10.1016/j.healthpol.2015.02.007 · Cited by 465
Jyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D., & Loke, Y. K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03071.x · Cited by 365
Self-citation
Metadata
- Authors
- Lenaghan, E., Holland, R., & Brooks, A.
- Affiliations
- University of East Anglia (GB)
- Kelling Hospital (GB)
- Corresponding author
- Lenaghan, E.
- ORCID
- Holland, R.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-26
- Volume
- 36
- Issue
- 3
- Pages
- 292-297
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2147463647
- Cited by
- 182
- References
- 14
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 12 · 2023: 24 · 2022: 4 · 2021: 10 · 2020: 17 · 2019: 8 · 2018: 13 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 9 · 2013: 11 · 2012: 15
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- community pharmacy, older adults, hospitalization, prescribing reduction, pharmaceutical care, polypharmacy, quality of life, nursing home admission, primary care
- MeSH terms
- Aged, 80 and over, Community Pharmacy Services, England, Homes for the Aged, House Calls, Humans, Mortality, Outcome and Process Assessment, Health Care, Patient Admission, Patient Care Team, Patient Compliance, Patient Education as Topic, Primary Health Care, Quality of Life, Risk Factors, Poisson Distribution, Caregivers, Drug Utilization Review, Polypharmacy, Interdisciplinary Communication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.